NDC 0597-0122

Zantac 75

Ranitidine

Zantac 75 is a Oral Tablet, Coated in the Human Otc Drug category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals Inc.. The primary component is Ranitidine Hydrochloride.

Product ID0597-0122_4bc42463-66dd-ea6e-379c-d319c60fa4dc
NDC0597-0122
Product TypeHuman Otc Drug
Proprietary NameZantac 75
Generic NameRanitidine
Dosage FormTablet, Coated
Route of AdministrationORAL
Marketing Start Date2006-12-21
Marketing CategoryNDA / NDA
Application NumberNDA020520
Labeler NameBoehringer Ingelheim Pharmaceuticals Inc.
Substance NameRANITIDINE HYDROCHLORIDE
Active Ingredient Strength75 mg/1
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 0597-0122-01

2 POUCH in 1 CARTON (0597-0122-01) > 1 TABLET, COATED in 1 POUCH
Marketing Start Date2006-12-21
Marketing End Date2021-11-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0597-0122-54 [00597012254]

Zantac 75 TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020520
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2006-12-21
Marketing End Date2021-11-30

NDC 0597-0122-92 [00597012292]

Zantac 75 TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020520
Product TypeHUMAN OTC DRUG
Marketing Start Date2006-12-21
Marketing End Date2016-03-02

NDC 0597-0122-13 [00597012213]

Zantac 75 TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020520
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2006-12-21
Marketing End Date2021-11-30

NDC 0597-0122-40 [00597012240]

Zantac 75 TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020520
Product TypeHUMAN OTC DRUG
Marketing Start Date2006-12-21
Marketing End Date2021-11-30

NDC 0597-0122-61 [00597012261]

Zantac 75 TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020520
Product TypeHUMAN OTC DRUG
Marketing Start Date2006-12-21
Marketing End Date2021-11-30

NDC 0597-0122-81 [00597012281]

Zantac 75 TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020520
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2006-12-21
Marketing End Date2021-11-30

NDC 0597-0122-34 [00597012234]

Zantac 75 TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020520
Product TypeHUMAN OTC DRUG
Marketing Start Date2006-12-21
Marketing End Date2021-11-30

NDC 0597-0122-08 [00597012208]

Zantac 75 TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020520
Product TypeHUMAN OTC DRUG
Marketing Start Date2006-12-21
Marketing End Date2021-11-30

NDC 0597-0122-01 [00597012201]

Zantac 75 TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020520
Product TypeHUMAN OTC DRUG
Marketing Start Date2006-12-21
Marketing End Date2021-11-30

NDC 0597-0122-37 [00597012237]

Zantac 75 TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020520
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2006-12-21
Marketing End Date2021-11-30

NDC 0597-0122-27 [00597012227]

Zantac 75 TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020520
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2006-12-21
Marketing End Date2016-03-02

NDC 0597-0122-96 [00597012296]

Zantac 75 TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020520
Product TypeHUMAN OTC DRUG
Marketing Start Date2006-12-21
Marketing End Date2021-11-30

NDC 0597-0122-57 [00597012257]

Zantac 75 TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020520
Product TypeHUMAN OTC DRUG
Marketing Start Date2012-05-14
Marketing End Date2016-03-02

NDC 0597-0122-74 [00597012274]

Zantac 75 TABLET, COATED
Marketing CategoryNDA
Application NumberNDA020520
Product TypeHUMAN OTC DRUG
Marketing Start Date2006-12-21
Marketing End Date2012-05-14

Drug Details

Active Ingredients

IngredientStrength
RANITIDINE HYDROCHLORIDE75 mg/1

OpenFDA Data

SPL SET ID:08556131-069b-4a1e-9190-98d3b62ada79
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 312773
  • 827183

    • NDC Crossover Matching brand name "Zantac 75" or generic name "Ranitidine"

    NDCBrand NameGeneric Name
    0597-0122Zantac 75ranitidine
    67751-152Zantac 75Zantac 75
    68151-2584Zantac 75Zantac 75
    50269-222Zantac 75Zantac 75
    10202-8527 Select Acid ReducerRanitidine
    0904-6350Acid ReducerRanitidine
    0113-7950basic care acid reducerRanitidine
    0113-7852basic care acid reducer 150Ranitidine
    0113-7876basic care acid reducer 75Ranitidine
    0113-0852Good Sense Acid ReducerRanitidine
    0113-0876Good Sense Acid ReducerRanitidine
    10202-712MAXIMUM STRENGTH RANITIDINERanitidine
    0597-0121Maximum Strength Zantacranitidine
    0121-0727RanitidineRANITIDINE
    0121-4727RanitidineRANITIDINE
    0172-4357RanitidineRanitidine
    0172-4358RanitidineRanitidine
    0363-0352RanitidineRanitidine
    0440-8300RanitidineRanitidine
    0440-8305RanitidineRanitidine
    0615-4513RanitidineRanitidine
    0615-4514RanitidineRanitidine
    0615-8021RanitidineRanitidine
    0781-6087RanitidineRanitidine
    0904-6349RanitidineRanitidine
    0904-6716RanitidineRanitidine
    0904-6921RanitidineRanitidine
    10544-056RanitidineRanitidine
    10544-438RanitidineRanitidine
    10544-516RanitidineRanitidine
    11673-849RanitidineRanitidine
    0904-6715ranitidine 75Ranitidine
    11673-023up and up ranitidineRanitidine
    0363-0852wal zan 150Ranitidine
    0363-0950wal zan 150Ranitidine
    0363-1876wal zan 75Ranitidine
    0363-0362Wal-ZanRanitidine
    0597-0120Zantac Maximum Strength 150 Cool Mintranitidine

    Trademark Results [Zantac 75]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ZANTAC 75
    ZANTAC 75
    77065456 not registered Dead/Abandoned
    Boehringer Ingelheim Pharmaceuticals, Inc
    2006-12-15
    ZANTAC 75
    ZANTAC 75
    74559569 2016139 Live/Registered
    CHATTEM, INC.
    1994-08-09
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.